IDEXX Laboratories Contracts & Agreements
87 Contracts & Agreements
- Business Finance (20 contracts)
- Business Operations (8)
- Human Resources (38)
- Uncategorized (21)
- Suspension of Rights Agreement dated May 2, 2024 to the Fourth Amended and Restated Credit Agreement, by and among the Borrowers, JPMorgan Chase Bank, N.A., as Administrative... (Filed With SEC on August 6, 2024)
- Third Amended and Restated Employment Agreement, dated August 2, 2024, by and between the Company and Jonathan J. Mazelsky (Filed With SEC on August 6, 2024)
- Form of Change in Control Agreement, by and between each of the Companys Executive Officers, other than the Chief Executive Officer (Filed With SEC on August 6, 2024)
- Form of Employee Stock Option Agreement for grants in 2013 to 2015 (Filed With SEC on August 6, 2024)
- Consulting Agreement effective May 7, 2024 by and between IDEXX Laboratories, Inc. and James F. Polewaczyk (Filed With SEC on May 10, 2024)
- Summary of Executive Incentive Plan (Filed With SEC on February 22, 2024)
- Employee Leveraged Restricted Stock Unit Agreement (Filed With SEC on February 22, 2024)
- Letter agreement between Ortho-Clinical Diagnostics, Inc., IDEXX B.V. and IDEXX Operations, Inc. dated July 28, 2023 (Filed With SEC on November 1, 2023)
- Summary of Executive Incentive Plan (Filed With SEC on February 16, 2023)
- Form of Confidential Information, Work Product, and Restrictive Covenant Agreement with each of the Companys Executive Officers (Filed With SEC on May 4, 2022)
- Fourth Amended and Restated Credit Agreement, dated as of December 9, 2021, among the Company, IDEXX Distribution, Inc., IDEXX Operations, Inc., OPTI Medical Systems, Inc., IDEXX... (Filed With SEC on December 9, 2021)
- Amendment No. 7 to U.S. Supply Agreement effective as of July 9, 2019, among IDEXX Operations, Inc., the Company and Ortho-Clinical Diagnostics, Inc. (Ortho) (Filed With SEC on November 2, 2021)
- Amendment No. 5 to European Supply Agreement effective as of July 9, 2019, among IDEXX Europe B.V., the Company and Ortho (Filed With SEC on November 2, 2021)
- Form of CEO Stock Option Agreement for grant in 2021 (Filed With SEC on May 4, 2021)
- Form of CEO Restricted Stock Agreement for grant in 2021 (Filed With SEC on May 4, 2021)
- IDEXX Laboratories, Inc. 1997 Employee Stock Purchase Plan, as amended (Filed With SEC on February 12, 2021)
- Summary of Executive Incentive Plan (Filed With SEC on February 12, 2021)
- Letter Agreement between Ortho-Clinical Diagnostics, Inc. and IDEXX Operations, Inc. and IDEXX Europe B.V. dated as of July 10, 2020 (Filed With SEC on October 29, 2020)
- Waiver to U.S. Supply Agreement, effective as of October 16, 2003, as amended, among IDEXX Operations, Inc., the Company and Ortho-Clinical Diagnostics, Inc. dated as of April 7,... (Filed With SEC on April 30, 2020)
- Amendment to Senior Advisory Agreement, dated April 14, 2020, by and between the Company and Mr. Jonathan W. Ayers (Filed With SEC on April 30, 2020)
- Amendment to Amended and Restated Multi-Currency Note Purchase and Private Shelf Agreement, dated as of May 9, 2019, among the Company, as issuer, each of the Subsidiary... (Filed With SEC on April 16, 2020)
- Second Amendment to Amended and Restated Multi-Currency Note Purchase and Private Shelf Agreement, dated as of April 10, 2020, among the Company, as issuer, each of the Subsidiary... (Filed With SEC on April 16, 2020)
- Amendment to Note Purchase Agreement, dated as of April 10, 2020, among the Company, as issuer, New York Life Insurance Company, New York Life Insurance and Annuity Corporation... (Filed With SEC on April 16, 2020)
- Amendment to Note Purchase Agreement, dated as of April 10, 2020, among the Company, as issuer, New York Life Insurance Company, New York Life Insurance and Annuity Corporation... (Filed With SEC on April 16, 2020)
- Second Amendment to Multicurrency Note Purchase and Private Shelf Agreement, dated March 23, 2020, among the Company, as issuer, each of the Subsidiary Guarantors (as defined... (Filed With SEC on March 27, 2020)
- Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 14, 2020)
- Summary of Executive Incentive Plan (Filed With SEC on February 14, 2020)
- Form of Director Restricted Stock Unit (Filed With SEC on February 14, 2020)
- Form of Employee Stock Option Agreement for grants in 2020 (Filed With SEC on February 14, 2020)
- Form of Employee Restricted Stock Unit for grants in 2020 (Filed With SEC on February 14, 2020)
- Mutual Separation Agreement, dated October 23, 2019, by and between IDEXX Laboratories Inc. and Mr. Jonathan W. Ayers (Filed With SEC on October 24, 2019)
- Senior Advisory Agreement, dated October 23, 2019, by and between IDEXX Laboratories Inc. and Mr. Jonathan W. Ayers (Filed With SEC on October 24, 2019)
- Second Amended and Restated Employment Agreement, dated October 23, 2019, by and between IDEXX Laboratories Inc. and Jonathan (Jay) Mazelsky (Filed With SEC on October 24, 2019)
- Form of Director Stock Option Agreement, pursuant to the 2018 Stock Incentive Plan (Filed With SEC on February 15, 2019)
- Form of Employee Stock Option Agreement, pursuant to the 2018 Stock Incentive Plan (Filed With SEC on February 15, 2019)
- Form of Employee Restricted Stock Unit Agreement pursuant to the 2018 Stock Incentive Plan (Filed With SEC on February 15, 2019)
- Form of Performance-Based Restricted Stock Unit Agreement pursuant to the 2018 Stock Incentive Plan (Filed With SEC on February 15, 2019)
- Form of High-Performer Restricted Stock Unit Agreement pursuant to the 2018 Stock Incentive Plan (Filed With SEC on February 15, 2019)
- Retirement Agreement dated May 24, 2018, between the Company and Jacqueline L. Studer (Filed With SEC on August 1, 2018)
- Form of Employee Stock Option Agreement, as amended, pursuant to the 2009 Stock Incentive Plan (Filed With SEC on February 16, 2018)
- Form of Performance-Based Restricted Stock Unit Agreement, as amended, pursuant to the 2009 Stock Incentive Plan (Filed With SEC on February 16, 2018)
- Amendment No. 6 to U.S. Supply Agreement effective as of January 1, 2017, between the Company and Ortho (Filed With SEC on February 16, 2018)
- Form of Employee Restricted Stock Unit Agreement pursuant to the 2009 Stock Incentive Plan (Filed With SEC on February 16, 2018)
- Director Stock Option Agreement Granted Under IDEXX Laboratories, Inc. 2009 Stock Incentive Plan (Filed With SEC on February 17, 2016)
- Employee Stock Option Agreement Granted Under IDEXX Laboratories, Inc. 2009 Stock Incentive Plan (Filed With SEC on February 17, 2016)
- Restricted Stock Unit Agreement Granted Under IDEXX Laboratories, Inc. 2009 Stock Incentive Plan (Filed With SEC on February 17, 2016)
- Performance-Based Restricted Stock Unit Agreement Granted Under IDEXX Laboratories, Inc. 2009 Stock Incentive Plan (Filed With SEC on February 17, 2016)
- SECOND AMENDED AND RESTATED CREDIT AGREEMENT dated as of December 4, 2015 among IDEXX LABORATORIES, INC., IDEXX DISTRIBUTION, INC., IDEXX OPERATIONS, INC., OPTIMEDICAL SYSTEMS,... (Filed With SEC on December 8, 2015)
- IDEXX LABORATORIES, INC. 1997 EMPLOYEE STOCK PURCHASE PLAN As of June 16, 2015 (Filed With SEC on July 30, 2015)
- AMENDED AND RESTATED CREDIT AGREEMENT dated as of June 18, 2014 among IDEXX LABORATORIES, INC., IDEXX DISTRIBUTION, INC., IDEXX OPERATIONS, INC., IDEXXREFERENCE LABORATORIES,... (Filed With SEC on July 25, 2014)
- IDEXX LABORATORIES, INC. 2014 INCENTIVE COMPENSATION PLAN I. Purposes (Filed With SEC on July 25, 2014)
- AMENDED AND RESTATED CREDIT AGREEMENT dated as of June 18, 2014 among IDEXX LABORATORIES, INC., IDEXX DISTRIBUTION, INC., IDEXX OPERATIONS, INC., IDEXXREFERENCE LABORATORIES,... (Filed With SEC on June 24, 2014)
- AMENDMENT NO.4 TO AGREEMENT (Filed With SEC on February 18, 2014)
- AMENDMENT NO.5 TO AGREEMENT (Filed With SEC on February 18, 2014)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 23, 2013)
- FORM OF AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 23, 2013)
- AMENDED AND RESTATED CREDIT AGREEMENT dated as of May 9, 2013 among IDEXX LABORATORIES, INC., IDEXX DISTRIBUTION, INC., IDEXX OPERATIONS, INC., IDEXX REFERENCE LABORATORIES, INC.,... (Filed With SEC on May 13, 2013)
- AMENDMENT NO. 4 TO AGREEMENT (Filed With SEC on February 17, 2012)
- AMENDMENT NO. 3 TO AGREEMENT (Filed With SEC on February 17, 2012)
- FORM OF EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 17, 2012)
- FORM OF EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 17, 2012)
- FORM OF EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 21, 2011)
- FORM OF EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 21, 2011)
- Exhibit 10.3 (Filed With SEC on April 21, 2011)
- IDEXXLaboratories, Inc. DIRECTORDEFERRED COMPENSATION PLAN RestatedEffective as of July 14, 2010 (Filed With SEC on October 22, 2010)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 7, 2010)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 7, 2010)
- FORM OF EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 7, 2010)
- ConfidentialMaterialsomittedandfiledseparatelywiththe SecuritiesandExchangeCommission.Asterisksdenoteomissions. Exhibit10.1 (Filed With SEC on July 23, 2010)
- IDEXXLaboratories, Inc. DIRECTORDEFERRED COMPENSATION PLAN RestatedEffective as of May 6, 2009 (Filed With SEC on July 23, 2010)
- IDEXXLaboratories, Inc. EXECUTIVEDEFERRED COMPENSATION PLAN RestatedEffective as of May 6, 2009 (Filed With SEC on July 23, 2010)
- DirectorStock Option Agreement GrantedUnder IDEXX Laboratories, Inc. 2009 Stock Incentive Plan (Filed With SEC on April 23, 2010)
- EmployeeStock Option Agreement GrantedUnder IDEXX Laboratories, Inc. 2009 Stock Incentive Plan (Filed With SEC on April 23, 2010)
- Point-of-care veterinary diagnostic products, comprising rapid assays, and instruments and consumables (Filed With SEC on February 19, 2010)
- Point-of-care veterinary diagnostic products, comprising rapid assays, and instruments and consumables (Filed With SEC on February 19, 2010)
- Point-of-care veterinary diagnostic products, comprising rapid assays and instruments and consumables (Filed With SEC on February 27, 2008)
- Point-of-care veterinary diagnostic products, comprising rapid assays and instruments and consumables (Filed With SEC on February 27, 2008)
- Point-of-care veterinary diagnostic products, comprising rapid assays and instruments and consumables (Filed With SEC on February 27, 2008)
- Point-of-care veterinary diagnostic products, comprising rapid assays and instruments and consumables (Filed With SEC on February 27, 2008)
- Point-of-care veterinary diagnostic products, comprising rapid assays and instruments and consumables (Filed With SEC on February 27, 2008)
- Point-of-care veterinary diagnostic products, comprising rapid assays and instruments and consumables (Filed With SEC on February 27, 2008)
- Point-of-care veterinary diagnostic products, comprising rapid assays and instruments and consumables (Filed With SEC on February 27, 2008)
- Current Assets (Filed With SEC on July 31, 2007)
- EX-10.7 U.S. SUPPLY AGREEMENT (Filed With SEC on March 3, 2004)
- EX-10.8 EUROPEAN SUPPLY AGREEMENT (Filed With SEC on March 3, 2004)
- EX-10.13 EXECUTIVE EMPLOYMENT AGREEMENT (WALLEN) (Filed With SEC on March 3, 2004)
- EX-10.14 LETTER AGREEMENT WILLIAM C. WALLEN (Filed With SEC on March 3, 2004)